ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE: STJ) announced today its wireless PressureWire™ Aeris technology, which aids in the diagnosis and treatment of coronary artery blockages by measuring Fractional Flow Reserve (FFR), will now be available to hospitals using the McKesson Horizon Cardiology Hemo™ solution. Through a new agreement with McKesson, physicians will have greater access to the market’s only wireless FFR measurement system.
